Relationship between Methylation Status of Multi-drug Resistance Protein (MRP) and Multi-drug Resistance in Lung Cancer Cell Lines

被引:0
作者
Li, Hong [2 ]
Zhu, Yi-Fei [1 ]
Zheng, Shi-Ying [1 ]
Jiang, Dong [1 ]
机构
[1] Suzhou Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Suzhou 215006, Jiangsu Prov, Peoples R China
[2] Suzhou Univ, Affiliated Hosp 1, Dept Geriatr, Suzhou 215006, Jiangsu Prov, Peoples R China
来源
2009 INTERNATIONAL CONFERENCE ON FUTURE BIOMEDICAL INFORMATION ENGINEERING (FBIE 2009) | 2009年
关键词
Lung cancer; Multi-drug resistance protein(MRP); Methylation Multi-drug resistance(MDR); CPG HYPERMETHYLATION; PROSTATE-CANCER; PROMOTER REGION; GENE; ALPHA;
D O I
10.1109/FBIE.2009.5405779
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: To study the relationship between the methylation status of multi-drug resistance protein (MRP) gene and the expression of its mRNA and protein in lung cancer cell lines. Methods:Human lung cell line WI-38.lung adenocarcinoma cell line SPCA-1 and its drug-resistant cells induced by different concentrations of doxorubicin were treated with restriction endonuclease Eco47III.The methylation status of MRP was examined by PCR,and the expressions of its mRNA and protein were evaluated by in situ hybridization and immunohistochemistry. Resuits: MRP gene promoter region of WI-38 cells was in hypermethylation status.but the promoter region of MRP in SPCA-1 cells and their resistant derivatives induced by different concentrations of doxorubicin were in hypomethylation status.There were Significant differences in the expression of MRP mRNA among WI-38 cell line.SPCA-1 cells and their drug-resistan t derivatives induced by different con- centration of doxorubicin.Consistently.MRP immunostaining presented similar significant differences. Conclusion:The promoter region of MRP in SPCA-1 lung adenocarcinoma cells was in hypomethylation status. The hypomethylation status of regulatory region of MRP promoter is an important structural basis that can increase the activity of transcrip-tion and results in the development of drug resistan cc in lung cancer.
引用
收藏
页码:548 / +
页数:2
相关论文
共 50 条
  • [1] Relationship between Methylation Status of Multi-drug Resistance Protein(MRP) and Multi-drug Resistance in Lung Cancer Cell Lines
    柳瑞军
    钟竑
    ChineseJournalofCancerResearch, 2007, (04) : 277 - 282
  • [2] Relationship between methylation status of multi-drug resistance protein(MRP) and multi-drug resistance in lung cancer cell lines
    Liu Rui-jun
    Zhong Hong
    CHINESE JOURNAL OF CANCER RESEARCH, 2007, 19 (04) : 277 - 282
  • [3] Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria
    Roundhill, E. A.
    Burchill, S. A.
    BRITISH JOURNAL OF CANCER, 2012, 106 (06) : 1224 - 1233
  • [4] Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer
    Huang, Dabing
    Wang, Yong
    He, Yifu
    Wang, Gang
    Wang, Wei
    Han, Xinghua
    Sun, Yubei
    Lin, Lin
    Shan, Benjie
    Shen, Guodong
    Cheng, Min
    Bian, Geng
    Fang, Xiang
    Hu, Shilian
    Pan, Yueyin
    CANCER CELL INTERNATIONAL, 2018, 18
  • [5] Multi-drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam
    Nguyen, Quang Huy
    Nguyen, Thi Van Anh
    Banuls, Anne-Laure
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2025,
  • [6] Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells
    Medarova, Zdravka
    Pantazopoulos, Pamela
    Yoo, Byunghee
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [7] Abnormal saccharides affecting cancer multi-drug resistance (MDR) and the reversal strategies
    Wang, Meizhu
    Chen, Wenming
    Chen, Jiansheng
    Yuan, Sisi
    Hu, Jiliang
    Han, Bangxing
    Huang, Yahui
    Zhou, Wen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 220
  • [8] Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells
    Li, Yong
    Tan, Bi-bo
    Zhao, Qun
    Fan, Li-qiao
    Liu, Yu
    Wang, Dong
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (06) : 3603 - 3610
  • [9] Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges
    Duan, Chunyan
    Yu, Mingjia
    Xu, Jiyuan
    Li, Bo-Yi
    Zhao, Ying
    Kankala, Ranjith Kumar
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [10] Strategies and validation for siRNA-based therapeutics for the reversal of multi-drug resistance in cancer
    Fatemian, Tahereh
    Othman, Iekhsan
    Chowdhury, Ezharul Hoque
    DRUG DISCOVERY TODAY, 2014, 19 (01) : 71 - 78